Surgeons at Aster RV Hospitals achieve milestone with removal of 345 gallstones
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Yesafili, received marketing authorization approval from the European Commission for the European Union
Subscribe To Our Newsletter & Stay Updated